The MS-LINK™ Outcomes Study

CompletedOBSERVATIONAL
Enrollment

2,182

Participants

Timeline

Start Date

March 24, 2021

Primary Completion Date

January 31, 2024

Study Completion Date

May 31, 2024

Conditions
Multiple Sclerosis
Trial Locations (9)

20057

Georgetown University, Washington D.C.

30327

Atlanta Neuroscience Institute, Atlanta

35209

Alabama Neurology Associates, Birmingham

48867

Memorial healthcare, Owosso

73104

The Oklahoma Medical Research Foundation, Oklahoma City

78229

University of Texas Health, San Antonio

78759

The University of Texas of Austin, Austin

02215

Beth Israel Deaconess Medical Center, Boston

68198-7835

University of Nebraska medical Center, Omaha

All Listed Sponsors
lead

EMD Serono Research & Development Institute, Inc.

INDUSTRY

NCT04735406 - The MS-LINK™ Outcomes Study | Biotech Hunter | Biotech Hunter